Literature DB >> 3203716

The pharmacokinetics of cefixime in the fasted and fed state.

R D Faulkner1, W Bohaychuk, J D Haynes, R E Desjardins, A Yacobi, B M Silber.   

Abstract

Twenty healthy adult volunteers received single 400 mg oral doses of cefixime in an open, randomized, crossover study, administered twice in the fasted state and twice with a standard breakfast. The study design allowed both an evaluation of a potential food effect and also an analysis of both intrasubject and intersubject variability in the fasted and fed state. There was a small but significantly longer (approximately 1 h) time to peak concentration when the drug was given with food. Peak serum concentrations, area under the curve, and 24 h urinary recovery values were unchanged in the fed and fasted states. The terminal elimination half-life of the drug given after a meal (3.6 h) was slightly longer than that observed after dosing in the fasting condition (3.5 h). The intrasubject and intersubject variabilities were less than 12% and 33% respectively, for both area under the curve and 24 h urinary recovery, and were virtually the same for the fasted and fed occasions. Therefore, the drug may be administered with or without food.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3203716     DOI: 10.1007/bf01046715

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

Review 1.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

2.  Influence of probenecid and food on the bioavailability of cephradine in normal male subjects.

Authors:  T W Mischler; A A Sugerman; D A Willard; L J Brannick; E S Neiss
Journal:  J Clin Pharmacol       Date:  1974 Nov-Dec       Impact factor: 3.126

3.  A human pharmacology study of cefaclor.

Authors:  A Glynne; R A Goulbourn; R Ryden
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

4.  Bioavailability of cephalexin in children: relationship to drug formulations and meals.

Authors:  T R Tetzlaff; G H McCracken; M L Thomas
Journal:  J Pediatr       Date:  1978-02       Impact factor: 4.406

Review 5.  The influence of food on the absorption of antimicrobial agents.

Authors:  P G Welling; F L Tse
Journal:  J Antimicrob Chemother       Date:  1982-01       Impact factor: 5.790

6.  The assessment of the intrasubject variability in digoxin absorption in man from two oral dosage forms.

Authors:  A Yacobi; R G Stoll; G C Chao; R A Schwartz; D J Weidler; J W Ayers; E Sakmar; M Hallmark; J G Wagner
Journal:  J Clin Pharmacol       Date:  1981-07       Impact factor: 3.126

7.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

8.  Cephradine absorption and excretion in fasting and nonfasting volunteers.

Authors:  C Harvengt; P De Schepper; F Lamy; J Hansen
Journal:  J Clin Pharmacol New Drugs       Date:  1973-01

9.  The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.

Authors:  P E Williams; S M Harding
Journal:  J Antimicrob Chemother       Date:  1984-02       Impact factor: 5.790

10.  Pharmacokinetics of amoxicillin and ampicillin: crossover study of the effect of food.

Authors:  F N Eshelman; D A Spyker
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

View more
  11 in total

1.  [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].

Authors:  F Kees; K G Naber
Journal:  Infection       Date:  1990       Impact factor: 3.553

2.  Multiple-dose pharmacokinetics of ceftibuten in healthy volunteers.

Authors:  C Lin; E Radwanski; M Affrime; M N Cayen
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

3.  Pharmacokinetics and dose proportionality of ceftibuten in men.

Authors:  C Lin; J Lim; E Radwanski; A Marco; M Affrime
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 4.  Considerations in dosage selection for third generation cephalosporins.

Authors:  J H Yuk-Choi; C H Nightingale; T W Williams
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

5.  Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime.

Authors:  D P Healy; J V Sahai; L P Sterling; E M Racht
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 6.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

Review 7.  Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.

Authors:  A Markham; R N Brogden
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 8.  Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.

Authors:  R N Brogden; D M Campoli-Richards
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

9.  Relationship between renal function and disposition of oral cefixime.

Authors:  M Dhib; B Moulin; A Leroy; B Hameau; M Godin; R Johannides; J P Fillastre
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra).

Authors:  Melanie M Taylor; Edna Oliveira Kara; Maria Alix Leite Araujo; Mariangela Freitas Silveira; Angelica Espinosa Miranda; Ivo Castelo Branco Coelho; Maria Luiza Bazzo; Gerson Fernando Mendes Pereira; Silvana Pereira Giozza; Ximena Pamela Díaz Bermudez; Maeve B Mello; Ndema Habib; My Huong Nguyen; Soe Soe Thwin; Nathalie Broutet
Journal:  BMC Infect Dis       Date:  2020-06-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.